HB0025: Clinical Trials

2 trials of HB0025, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1
Phase 11Recruiting 1

Follow HB0025: new trials by email Literature Review of HB0025 trials Research Report on HB0025

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
HB0025, Pemetrexed, Paclitaxel - Advanced NSCLC, Advanced Endometrial Cancer
Phase 1 / Phase 2RecruitingHuabo Biopharm Co., Ltd.2822024-01-312025-01-23
A Study of HB0025 Injection in Patients With Advanced Renal Cancer
HB0025 - Renal Cancer
Phase 2UnknownHuabo Biopharm Co., Ltd.1002023-01-302024-01-24

Conditions studied

Endometrial Neoplasms (1)  ·  Kidney Neoplasms (1)

Sponsors

Huabo Biopharm Co., Ltd. (2)

Countries

China (2)

Top investigators

Caicun Zhou, PhD. (1)  ·  Dingwei Ye, MD/PHD (1)  ·  Jundong Li, PhD. (1)